Yarlagadda S. Babu, Senior VP - Drug Discovery at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 60,000 shares at $4.06 ($244K) on 2016-08-25, disclosed to the SEC on 2016-08-29.
Open-market sale of $244k BCRX by Senior VP - Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.06 | 30,000 | $122K | 50.0% |
| 2 | $4.06 | 30,000 | $122K | 50.0% |
| Total | $4.06 avg | 60,000 | $244K | 100% |
| Filing → |
| BCRX | SELL | 2021-12-09 | $367K | — | Filing → |
| BCRX | BUY | 2019-11-18 | $36K | — | Filing → |
| BCRX | SELL | 2015-03-20 | $123K | — | Filing → |